Cara Therapeutics, Inc. (CARA) Covered Calls
Cara Therapeutics Inc is a clinical-stage biopharmaceutical company developing and commercializing new chemical entities designed to alleviate pain by selectively targeting kappa opioid receptors.
There are no covered calls available for Cara Therapeutics, Inc..
Born To Sell's covered call screener gives you full search capabilities so you can find stocks and ETFs that make good covered call candidates.
Want to make money with covered calls? Sign Up For A Free Trial
Extended Business Description
CARA Therapeutics, Inc. is an emerging biotechnology company focused on developing novel therapeutics to treat human diseases associated with pain, inflammation and pruritus. The company involves in the developing of novel and proprietary class of product candidates that target the body's peripheral nervous system and have demonstrated efficacy in patients with moderate-to-severe pain without undesirable side effects typically associated with currently available pain therapeutics. Its product candidate includes I.V. CR845, Oral CR845 and CR701. CARA Therapeutics was founded by Derek T. Chalmers, Michael E. Lewis and Frédérique Menzaghi on July 2, 2004 and is headquartered in Shelton, CT.
Top 10 Open Interest For Feb 21 Expiration | Top 5 High Yield | |||||
---|---|---|---|---|---|---|
1. | NVDA covered calls | 6. | FXI covered calls | 1. | RGTI covered calls | |
2. | TLT covered calls | 7. | TSLA covered calls | 2. | QUBT covered calls | |
3. | IWM covered calls | 8. | AMZN covered calls | 3. | DJT covered calls | |
4. | SPY covered calls | 9. | ASHR covered calls | 4. | MSTR covered calls | |
5. | SLV covered calls | 10. | AAPL covered calls | 5. | SOUN covered calls |
Want more examples? CAR Covered Calls | CARE Covered Calls